Entamoeba histolytica, an amitochondriate protozoan parasite that relies on glycolysis as a key pathway for ATP generation, has developed a unique extended PP i -dependent glycolytic pathway in which ADP-forming acetyl-coenzyme A (CoA) synthetase (ACD; acetate:CoA ligase [ADP-forming]; EC 6.2.1.13) converts acetyl-CoA to acetate to produce additional ATP and recycle CoA. We characterized the recombinant E. histolytica ACD and found that the enzyme is bidirectional, allowing it to potentially play a role in ATP production or in utilization of acetate. In the acetate-forming direction, acetyl-CoA was the preferred substrate and propionyl-CoA was used with lower efficiency. In the acetyl-CoA-forming direction, acetate was the preferred substrate, with a lower efficiency observed with propionate. The enzyme can utilize both ADP/ATP and GDP/GTP in the respective directions of the reaction. ATP and PP i were found to inhibit the acetate-forming direction of the reaction, with 50% inhibitory concentrations of 0.81 ؎ 0.17 mM (mean ؎ standard deviation) and 0.75 ؎ 0.20 mM, respectively, which are both in the range of their physiological concentrations. ATP and PP i displayed mixed inhibition versus each of the three substrates, acetyl-CoA, ADP, and phosphate. This is the first example of regulation of ACD enzymatic activity, and possible roles for this regulation are discussed.
that from the amitochondriate Giardia lamblia (8) (9) (10) , for which only substantial acetate-forming activity has been detected (10) .
Although not widespread, ACD has been identified in all three domains and is postulated in the conversion of acetyl-CoA to acetate. In archaea, ACD was first identified in Pyrococcus furiosus (11, 12) , a thermophilic anaerobe that ferments carbohydrates and peptides, and it has now been identified in a number of other archaea, including the thermophilic anaerobes Pyrococcus woesei, Desulfurococcus amylolyticus, Hyperthermus butylicus, and Thermococcus celer (13, 14) , the hyperthermophilic anaerobic sulfate reducer Archaeoglobus fulgidus (15) , and the halophilic aerobe Halobacterium saccharovorum (13, 14) . Native ACD has been purified from P. furiosus (11, 12) and Haloarcula marismortui (16) , and recombinant ACDs have been characterized from P. furiosus (17) , A. fulgidus (18) , Methanococcus jannaschii (18) , H. marismortui (16) , Pyrobaculum aerophilum (16) , and Thermococcus kodakarensis (19) .
A similar role for ACD in acetate production has been proposed in bacteria. Most bacteria have a phosphotransacetylase (PTA) and acetate kinase (ACK), which form a predominant pathway for acetate production from acetyl-CoA. ACD from the phototrophic Chloroflexus aurantiacus has recently been purified, and the recombinant enzyme was characterized (20) . The syntrophs Pelotomaculum thermopropionicum (21) and Syntrophus aciditrophicus (22) and the propionic acid-producing Propionibacterium acidipropionici (23) all lack genes for the PTA-ACK pathway and instead have acd genes. ACD has been identified via proteome analysis of P. acidipropionici cells grown under acetateproducing conditions, but the enzyme has not been purified or characterized (23) . Likewise, the acetate-producing archaea listed above that have ACD lack genes encoding the PTA-ACK pathway.
ACD is part of a superfamily of nucleoside diphosphate-forming acyl-CoA synthetases, which includes the closely related citric acid cycle enzyme succinyl-CoA synthetase (SCS; EC 6.2.1.4) as well as ATP citrate lyase (EC 2.3.3.8) and malate thiokinase (EC 6.3.1.9) (9) . SCS has been extensively studied kinetically and structurally (24) (25) (26) , and a three-step enzymatic mechanism has been proposed (27) , with E in the equations representing the enzyme of interest: (i) succinyl-CoA ϩ P i % Eϳsuccinyl-P ϩ CoA; (ii) Eϳsuccinyl-P % E-HisϳP ϩ succinate; (iii) E-HisϳP ϩ ADP % ATP.
Based on their studies with P. furiosus ACD, Brasen et al. (28) proposed that ACD proceeds through a mechanism similar to that of SCS, but with an additional step in which the phosphoryl group is transferred from a His residue on the ␣-subunit to a His residue on the ␤-subunit before transfer to ADP in the final step to produce ATP. Here we report the biochemical and kinetic characterizations of the recombinantly produced ACD from the intestinal parasite E. histolytica and reveal its ability to function in either acetate production or utilization in vitro. Our results confirm that both the acetyl-CoA-forming and acetate-forming activities of ACD are present in cell lysates from E. histolytica trophozoites. Inhibition studies suggest E. histolytica ACD (EhACD) is regulated through inhibition by ATP and PP i in the acetate-forming direction.
MATERIALS AND METHODS

Materials.
Chemicals were purchased from Sigma-Aldrich, VWR International, Gold Biotechnology, Fisher Scientific, Atlanta Biological, Life Technologies, and JR Scientific.
Growth of E. histolytica trophozoites and preparation of cell lysates. E. histolytica strain HM-1:IMSS (kindly provided by Lesly Temesvari, Clemson University) was cultured axenically at 37°C in TYI-S-33 medium (29) . Cells were harvested by incubation on ice for 10 min and centrifugation at ϳ350 ϫ g for 5 min at 4°C. The pellet was resuspended in 0.8 ml lysis buffer [50 mM Tris-HCl (pH 7.3), 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, 0.015 mM E-64, 0.02 mM pepstatin A, 5 mM 1,10-phenanthroline] and disrupted by five cycles of freezing in a dry ice/ethanol bath and thawing at 37°C. The cell lysate was kept on ice, and enzymatic activity was assayed immediately by using the 5,5=-dithio-bis-(2-nitrobenzoic acid) (DTNB) and hydroxamate assays described below. Total protein concentration was determined by using the Bradford method (30) with bovine serum albumin as the standard.
Production and purification of E. histolytica ACD. A codon-optimized E. histolytica acd gene was synthesized by Genscript and cloned into pET21b (Novagen) for production of recombinant E. histolytica ACD in Escherichia coli. The pET21b-ACD plasmid was transformed into E. coli Rosetta2(DE3)pLysS cells (Novagen), and cultures were grown in LuriaBertani medium (LB) containing 50 g ml Ϫ1 ampicillin and 34 g ml Ϫ1 chloramphenicol, with shaking at 200 rpm at 37°C to an A 600 of ϳ0.8. Protein production was initiated by the addition of isopropyl ␤-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. Cultures were grown overnight at ambient temperature and harvested by centrifugation. Cells were suspended in ice-cold buffer A (25 mM Tris-HCl, 150 mM NaCl, 10% glycerol, 20 mM imidazole [pH 7.4]) and disrupted by two passages through a French pressure cell at 138 MPa. The cell lysate was clarified via ultracentrifugation at ϳ 98,000 ϫ g for 1 h at 4°C, and cell extract was applied to a 5-ml HisTrap HP nickel affinity column (GE Healthcare) equilibrated with buffer A. After extensive washing with buffer A to remove unbound protein, the column was developed with a linear gradient of 0 to 0.5 M imidazole in buffer A. Fractions containing active enzyme were pooled, dialyzed overnight in buffer (25 mM Tris-HCl, 10% glycerol [pH 7.0]), aliquoted, and stored at Ϫ80°C. The enzyme was judged to be electrophoretically pure by SDS-PAGE analysis. Protein concentrations were determined based on the absorbance at 280 nm using a Take3 microvolume plate (BioTek). Determination of molecular mass. The native molecular mass of EhACD was determined by gel filtration chromatography through a Superose 12 column (GE Healthcare) preequilibrated with 50 mM Tris-HCl, 150 mM NaCl (pH 7.0). The column was calibrated with cytochrome c (12.4 Activity in the acetate-forming direction was confirmed using the hexokinase/glucose-6-phosphate dehydrogenase-coupled assay (32) . This assay couples ATP formation to the reduction of NADP ϩ to NADPH, which is measured spectrophotometrically at 340 nm. Reaction mixtures (100 mM Tris-HCl [pH 7.3], 5.5 mM glucose, 1 mM NADP ϩ , 0.2 mM dithiothreitol) with varied concentrations of substrates were preincubated at 37°C for 5.5 min, hexokinase and glucose-6-phosphate dehydrogenase were added, and the reactions were initiated by the addition of ACD. Assays were performed in 96-well plates in 0.2-ml reaction volumes, and absorbance was measured every 4 s at 37°C by using a Synergy HT multimode microplate reader (BioTek). Initial velocities were converted to micromoles of ATP formed by using an extinction coefficient of 6.22 mM Ϫ1 cm Ϫ1 for NADPH. Concentrations of nonvaried substrates used for both the DTNB assay and coupled enzyme assay were identical.
Enzymatic activity for determination of acetyl-CoA formation was detected using the hydroxamate assay (33, 34) . Reaction mixtures (50 mM Tris-HCl [pH 7.5], 300 mM hydroxylamine-HCl [pH 7.0]) with varied substrate concentrations were preincubated at 37°C for 5.5 min, and reactions were initiated by the addition of enzyme. Reactions (0.15-ml reaction volumes) were terminated by the addition of 1 volume of stop solution (2.5% FeCl 3 , 2 N HCl, 10% trichloroacetic acid), and the absorbance at 540 nm was measured. Product formation was determined by comparison to an acetyl-CoA standard curve. For acyl substrates prepared in ethanol, the final concentration of ethanol in the reaction mixture was kept at 2.5%, which was determined not to affect enzymatic activity. One unit of activity was defined as 1 micromole of acetyl-CoA produced per minute per milligram of protein. In determinations of kinetic parameters for acetyl-CoA formation, the nonvaried substrates were held at 100 mM acetate, 1 mM CoA, 20 mM MgCl 2 :ATP, and 25 mM MgCl 2 :GTP. For determination of kinetic parameters for propionyl-CoA formation, the nonvaried substrates were held at the following concentrations: 250 mM propionate, 3 mM CoA, and 20 mM MgCl 2 :ATP.
Apparent kinetic parameters were determined by varying the concentration of a single substrate while the concentrations of the other two substrates were held constant. For determination of the apparent steadystate kinetic parameters K m , k cat , and k cat /K m , and their standard deviations (SD), nonlinear regression in KaleidaGraph (Synergy Software) was used to fit the data to the Michaelis-Menten equation.
Determination of inhibition parameters. Various metabolic intermediates were tested as effectors of ACD. The IC 50 s (the effector concentrations that provided half-maximal inhibition) for inhibitors were determined based on K m substrate concentrations by measuring the decrease in enzymatic activity as a function of increasing concentration of inhibitor. Nonlinear regression analysis in Prism 5 (GraphPad Software) was used to fit the data to the log [inhibitor] versus response curve to determine IC 50 s. To examine the mode of inhibition, enzymatic activity was assayed in each direction in a four-by-four matrix of varied inhibitor concentrations versus varied concentrations of one substrate, with the other two substrate concentrations held constant. Linear regression in KaleidaGraph (Synergy Software) was used to resolve the points of intersection of the inverse plots.
RESULTS
General characterization. The limited characterization of partially purified native E. histolytica ACD reported by Reeves et al. (7) indicated that the enzyme has a narrow nucleotide specificity. To allow a more thorough characterization of the E. histolytica ACD (EhACD), we produced the recombinant enzyme in E. coli. A codon-optimized gene was synthesized by Genscript and cloned into the pET21b E. coli expression vector (Novagen), which encodes the addition of a C-terminal His 6 tag to the recombinant protein. The calculated subunit molecular mass of the recombinant His-tagged protein was 78,999 Da. The molecular mass of the purified enzyme was estimated to be ϳ150 kDa based on gel filtration chromatography, suggesting that EhACD is dimeric, as found with the G. lamblia ACD (10) . The optimum temperature for ACD activity was determined to be 55°C in the acetyl-CoAforming direction but could not be determined in the acetateforming direction due to limitations of the equipment used for measurements. This unexpectedly high optimal temperature may have been an artifact from the assay conditions or may represent an unusual stability of this protein, but it was not analyzed further. However, activity was routinely assayed at 37°C, the temperature E. histolytica trophozoites would typically encounter within the human host. The enzyme had approximately 70% activity at this temperature versus its optimum temperature.
The requirement for a divalent cation was examined and ACD was found to have the highest activity with Mg 2ϩ and Mn 2ϩ and substantial activity with Co 2ϩ in both directions of the reaction, but only weak activity with Ni 2ϩ , Zn 2ϩ , Ca 2ϩ , and Cu 2ϩ (Fig. 2) . The preference for Mg 2ϩ , Mn 2ϩ , and Co 2ϩ is similar to that of other ACDs (10, 11, 18) .
ACD enzymatic activity was observed in both directions of the reaction, and the reaction rate was linearly dependent on enzyme concentration. Specific activity in the acetate-forming direction (85 Ϯ 1.2 mol min Ϫ1 mg Ϫ1 ) was approximately half that observed in the acetyl-CoA-forming direction (180 Ϯ 2.0 mol min Ϫ1 mg Ϫ1 ). Similarly, measurement of ACD specific activity in E. histolytica cell extracts showed that activity in the acetate-forming direction was approximately half that in the acetyl-CoA-forming direction (0.14 Ϯ 0.022 mol min Ϫ1 mg Ϫ1 versus 0.29 Ϯ 0.004 mol min Ϫ1 mg Ϫ1 ). In contrast, ACD activity in Giardia cell extracts could only be detected in the direction of acetate formation (10) . Although the purified recombinant Giardia ACD had activity in both directions of the reaction, the acetyl-CoA-forming activity was ϳ4% of the acetate-forming activity (9) .
EhACD has a limited acyl-CoA substrate range, with the highest activity observed with acetyl-CoA and lower activity observed with propionyl-CoA (16% Ϯ 2.8% activity versus that with acetylCoA). Less than 1% activity was observed with isobutyryl-CoA and isovaleryl-CoA at a 0.3 mM final concentration, and no activity was observed with butyryl-CoA, succinyl-CoA, or phenylacetyl-CoA. ADP and GDP gave the highest activity (100% Ϯ 1.0% and 106% Ϯ 3.7% activity, respectively), although activity was also observed with IDP (28% Ϯ 3.8%), CDP (7.0% Ϯ 0.2%), and UDP (2.8% Ϯ 0.1%); no activity was observed with TDP as the substrate. PP i was tested with AMP as the phosphoryl acceptor, but no activity was observed under the conditions tested.
In the acyl-CoA-forming direction, acetate was the favored substrate and propionate and butyrate could also be used, with relative activities of 72% Ϯ 1.5% and 5.6% Ϯ 0.2%, respectively, versus acetate. Less than 4% activity was observed with isobutyrate, valerate, isovalerate, hexanoate, heptanoate, octanoate, succinate, or phenylacetate as the acyl substrate. Activity observed with ATP (representing 100% activity) was nearly double that with GTP (57% Ϯ 0.4%) and substantially higher than the activities observed with ITP (15% Ϯ 0.2%), CTP (4.1% Ϯ 0.3%), or UTP (1.6% Ϯ 0.2%); no activity was observed with TTP or PP i .
Kinetic parameters. Kinetic parameters for EhACD were determined in both the acetate-forming and acetyl-CoA-forming directions (Table 1) . Activity decreased at substrate concentrations above 6 mM ADP or 25 mM ATP in the respective directions of the reaction, so the concentrations of these substrates were held below saturation in determinations of kinetic parameters. Under these conditions, acetyl-CoA and P i in the acetate/ATP-forming direction and acetate and CoA in the acetyl-CoA-forming direction followed Michaelis-Menten-like kinetics. The enzyme displayed similar K m values for acetyl-CoA and propionyl-CoA in the acetate-forming direction of the reaction. However, the turnover rate, k cat , was approximately 5-fold higher with acetyl-CoA versus propionyl-CoA, resulting in ϳ4-fold-higher catalytic efficiency with acetyl-CoA. The K m for P i was similar with acetyl-CoA or propionyl-CoA as the acyl substrate, but the K m for ADP was reduced ϳ2-fold with propionyl-CoA versus acetyl-CoA. Similar K m and k cat values were observed with ADP and GDP ( Table 1 ). The K m values observed for EhACD are similar to those reported for the Giardia ACD (0.02 mM, 0.23 mM, and 1.59 mM for acetylCoA, ADP, and P i , respectively) (10) .
As the enzyme assay used for determination of kinetic parameters in the acetate-forming direction of the reaction measures the CoA release in the first step, we confirmed our results by using a coupled enzyme assay that measures ATP production in the last step of the reaction. Similar ). In the acetyl-CoA-forming direction of the reaction, the K m for acetate was ϳ2-fold higher than that for propionate (Table 1) ; however, the k cat values were similar for both substrates, unlike in the opposite direction. Thus, the catalytic efficiency of EhACD with acetate was only 2.6-fold higher than with propionate. The K m for CoA was ϳ2-fold elevated with propionate versus acetate as the acyl substrate, but the K m for ATP was slightly reduced. The K m values for ATP and GTP were similar, but the turnover rate was reduced 1.8-fold with GTP. The overall catalytic efficiency with ATP was only 1.5-fold higher than with GTP, indicating that both are suitable substrates. Although weak activity was observed with butyrate, kinetic parameters could not be determined, as the enzyme was unsaturable for butyrate even at concentrations as high as 1 M.
Enzyme inhibition. Since ACD can function to produce either ATP or acetyl-CoA, regulation of this enzyme may be important for maintaining proper levels of these metabolites in the cell. An array of metabolic intermediates was tested as effectors for ACD (Fig. 3) . ATP and PP i were found to be potent inhibitors in the acetate-forming direction of the reaction, producing greater than 95% inhibition at a 10 mM final concentration (Fig. 3) . Additionally, 50% or less activity was observed in the presence of 10 mM glyoxylate (32% Ϯ 2%), NAD ϩ (47% Ϯ 3%), or glucose-6-phosphate (50% Ϯ 5%). In the acetyl-CoA-forming direction, only weak to moderate inhibition was observed with any of the com- pounds tested (Fig. 3) . PP i had only a moderate effect in this direction, reducing activity to 64% Ϯ 4% when present at a 10 mM final concentration in the reaction mixture. ATP is a substrate in this direction, and although it does inhibit at higher concentrations, we did not examine this further.
In addition to the intermediates shown in Fig. 3 , glyceraldehyde-3-phosphate, phosphoenolpyruvate, and oxaloacetate were tested, but only in the acetyl-CoA-forming direction, because they interfere with the assays used for the acetate-forming direction. None of these compounds resulted in any substantial inhibition in this direction, with 85% Ϯ 0.3%, 85% Ϯ 5.1%, and 90% Ϯ 1.4% activity observed, respectively. IC 50 s for ATP and PP i in the acetate-forming direction were determined to be 0.81 Ϯ 0.17 mM for ATP and 0.83 Ϯ 0.27 mM for PP i . The estimated intracellular concentrations of ATP and PP i in E. histolytica trophozoites grown in the presence of glucose are 5 Ϯ 2 mM and 0.45 mM, respectively (35) , suggesting that regulation of the acetate-forming activity of ACD by ATP and PP i is biologically relevant. The mode of inhibition by each of these compounds was determined by kinetic analysis in which the concentration of inhibitor was varied versus one substrate and the concentrations of the other two substrates were held constant. These analyses suggested mixed inhibition by ATP (Fig. 4) and PP i (Fig. 5) versus each substrate.
DISCUSSION
Substrate specificity of EhACD and comparison to other characterized ACDs. Although ACD is not widespread, characterization of P. furiosus ACDs has demonstrated that there are at least two different isoforms (11, 12) . This was confirmed by characterization of additional enzymes from A. fulgidus (18) and T. kodakarensis (19) . The ACD I isoforms prefer acetate and acetyl-CoA and can typically utilize propionate, butyrate, and propionyl-CoA as well but do not tend to use longer or branched-chain acyl/acylCoA derivatives (11, 12, 16, 18, 20) . The ACD II isoforms prefer longer acyl/acyl-CoA derivatives, such as phenylacetyl-CoA/phenylacetate and indoleacetate as the substrates (12, 18, 19) . Based on our characterization of recombinant EhACD and the previous characterization of the partially purified native EhACD (7), this enzyme belongs to the ACD I class. The Giardia enzyme also appears to belong to this class (10) .
All ACDs utilize ADP, but the ability to accept GDP as a substrate varies (11, 12, 16) . In contrast to SCS, which has an isozyme specific for each (24) , and the G. lamblia ACD, which functions only with ADP (10), EhACD is able to utilize ADP and GDP interchangeably, with similar K m and k cat values for each. However, EhACD may be more likely to utilize ADP in vivo, since the estimated intracellular concentration of ADP is higher than that for termined in each direction of the reaction by using K m concentrations of substrate in the presence or absence of the indicated metabolites at a final concentration of 10 mM. Note that ATP was tested only in the acetate-forming direction, since it serves as a substrate in the acetyl-CoA-forming direction. Activities were normalized to the activity observed in the absence of added metabolites. Black bars, activities in the acetate-forming direction; gray bars, activities in the acetyl-CoA-forming direction. Reported activities are means Ϯ SD of three replicates. Abbreviations: cAMP, cyclic AMP; AcP, acetyl phosphate; G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; F16BP, fructose 1,6-bisphosphate.
FIG 4
The inhibitory effects of ATP versus ADP, acetyl-CoA, and phosphate in the acetate-forming direction. Activity was determined in the presence of various ATP concentrations, with the concentration of one substrate varied and the others held constant. ATP concentrations used were 0 mM (), 0.2 mM (OE), 0.35 mM (), and 0.5 mM (ᮀ). ATP inhibition patterns were observed versus ADP (A), acetyl-CoA (B), and KH 2 PO 4 (C). Reported activities are means Ϯ SD of three replicates. GDP (3.3 Ϯ 1.2 mM versus 0.7 mM, respectively [35] ). Furthermore, the intracellular concentration for ADP is above the K m value for ADP, whereas the intracellular GDP concentration is below the K m value. Like EhACD, Entamoeba phosphoglycerate kinase can use both ADP and GDP but shows a strong preference for GDP, as judged by the order-of-magnitude difference between the K m values for these substrates (4).
In the acetyl-CoA-forming direction of the reaction, the enzyme does not show a clear preference for ATP or GTP, as the kinetic parameters with each substrate are similar. The fact that the intracellular concentrations of ATP and GTP (5 Ϯ 2 mM and 1.8 mM, respectively [35] ) are both below the K m values for these substrates suggests that the acetate/ATP-forming direction of the reaction is favored in the cell, even though the purified enzyme has similar activity in both directions. The higher catalytic efficiency observed with either substrate in the acetate-forming direction versus the acetyl-CoA-forming direction is consistent with this.
A comparison of the characterized ACD I enzymes reveals a great deal of variability. All of the characterized enzymes catalyzed the acetate/ATP-forming reaction, but an acetyl-CoA-forming activity was not detected or was very low for the ACDs from G. lamblia (8) (9) (10) , P. aerophilum (16) , and M. jannaschii (18) . A range of K m values has been observed for each substrate in both directions of the reaction (Table 2) . Within the archaea, for which six ACD I enzymes have been characterized, the K m for a given substrate in the acetyl-CoA-forming direction showed up to an 11-fold range in values. In the acetate/ATP-forming direction, K m values ranged up to 41-fold for acetyl-CoA. The K m values observed for the single characterized bacterial ACD, from C. aurantiacus, were within the range of values observed with the archaeal enzymes. Likewise, the K m values observed for the G. lamblia enzyme were within or near the ranges of those for the archaeal enzymes.
For EhACD, the K m values for acetyl-CoA and P i were comparable to those for other enzymes, but the K m for ADP was substantially higher. In the acetyl-CoA-forming direction, the K m value for CoA was slightly above the range observed for other ACDs. However, the K m for acetate was 8-fold higher than the highest K m observed for any other ACD, and the K m for ATP was over 20-fold higher. This may suggest that acetyl-CoA formation is not the preferred direction of the reaction and that E. histolytica may employ this direction only under specific environmental or physiological conditions (see below).
Role of the extended glycolytic pathway. The PP i -dependent extended glycolytic pathway branches after production of acetylCoA from pyruvate. In one branch, ACD is responsible for production of acetate and ATP; in the other, acetyl-CoA is metabolized to ethanol by ADHE (6). Montalvo et al. (36) and Reeves et al. (7) showed that ethanol and acetate are produced at approximately a 2:1 ratio under anaerobic conditions versus a 1:2 ratio under aerobic conditions. More recently, Pineda et al. (37) found (20) . g Reported K m for Giardia lamblia (10) . h ND, no activity detected in the direction of acetyl-CoA formation. an ethanol-to-acetate ratio of 3.9:1 was produced in cells growing under standard conditions. Upon exposure to oxygen-saturated medium, however, the flux through acetate increased for up to 90 min. The flux through ethanol decreased but gradually recovered over time. Overall, these results suggest ethanol and acetate are both important end products of glycolysis and that flux through both of these pathways may be necessary to generate sufficient ATP while still providing for NAD ϩ recycling. ACD may also play a role in ATP production from amino acid catabolism. In addition to increasing ATP production from glycolysis, the presence of ACD and PFOR allows certain amino acids to be catabolized for ATP production. E. histolytica trophozoites scavenge a number of amino acids. Asparagine, aspartate, and tryptophan are broken down to pyruvate, and methionine, threonine, and homocysteine are broken down to 2-oxobutanoate (38) . PFOR converts these products, respectively, to acetyl-CoA and propionyl-CoA (7, 39, 40) , which can then serve as the substrates of ACD for ATP production.
Regulation of ACD activity. Although metabolic flux analysis using kinetic modeling suggested that ACD has little regulatory effect over glycolysis (35) , its roles in amino acid degradation were not taken into account. On the contrary, one might expect that ACD's position in the extended glycolytic pathway of E. histolytica makes it a prime site for regulation in order to properly maintain ATP and acetyl-CoA concentrations. In fact, we have found that EhACD is regulated by both ATP and PP i in the acetate-forming direction, with IC 50 s that are within the physiological range based on the estimated intracellular concentrations for each (35) . An excess of ATP would indicate that the energy needs of the cell are being met, and thus additional ATP production by ACD would be unnecessary. This would prevent costly depletion of acetyl-CoA, which could instead be used by other pathways.
PP i serves as a phosphoryl donor for two PP i -dependent glycolytic enzymes in E. histolytica (4) . A buildup of PP i may signal a backup in glycolysis, which would also warrant inhibition of ACD to prevent depletion of acetyl-CoA. Finally, regulation of ACD by two components of the glycolytic pathway may provide a means for shunting acetyl-CoA to ADHE for ethanol production to regenerate NAD ϩ , thus maintaining a proper balance between these two alternative pathways.
Differences between G. lamblia and E. histolytica allow these microorganisms to occupy diverse habitats. Although E. histolytica and G. lamblia rely on similar extended PP i -dependent glycolytic pathways, the E. histolytica ACD is able to function in both the acetate-forming and acetyl-CoA-forming directions of the reaction, whereas the Giardia enzyme is limited to just the acetateforming direction (10) . This divergence may have arisen due to the different environments these parasites inhabit during infection. Entamoeba trophozoites reside in the mucus layer of the colon, where bacterial microflora produce large amounts of the short-chain fatty acids (SCFA) acetate, propionate, and butyrate (41) . Giardia colonizes the small intestine, in which the SCFA concentration is relatively low (41) , and thus it is unlikely that ACD is needed in acetate utilization.
The total SCFA concentration in the human colon is approximately 100 to 120 mM, with relative molar ratios of 57:22:21 (acetate:propionate:butyrate) (41), giving approximate concentrations of 57 to 68 mM for acetate, 22 to 26 mM for propionate, and 21 to 25 mM for butyrate. Acetate and propionate concentrations are thus in a range that would suggest ACD's activity in the acetylCoA-forming direction may be physiologically relevant and that ACD may switch from acetate/ATP production when glucose is present to SCFA utilization when glucose becomes limiting.
Concluding remarks. Although we have speculated on the roles of ACD in Entamoeba, experimental confirmation is still required. In addition to Entamoeba and Giardia, ACD may also be present in other parasites, including Cryptosporidium muris, Blastocystis hominis, and Plasmodium falciparum. The possible existence of ACD in Plasmodium is of particular interest, not only because of its enormous public health significance but also because the parasites retain fully functional mitochondria. Within the complex life cycle of Plasmodium, the intraerythrocyte stages rely primarily on the incomplete oxidation of blood glucose by glycolysis to produce ATP (42, 43) , and thus ACD may play a similar role as in Entamoeba. Whether ACD plays similar roles in other parasites must still be investigated, and results from such studies may provide insights into energy metabolism in these important eukaryotic pathogens.
